Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBWNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.15.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.59 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBRNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DJ.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AZ.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.193NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.51NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EE.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.4.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.39.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.233NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.320NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.33NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.635NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.47.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DJ.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BW.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.74NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.6.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.238NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used